• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

55
22
15
13
9

COUNTRY

8
7
4
3
2

PRICE

82
117
135
228

PUBLISHED

1
3
24
228

PRODUCT TYPE

188
35
3
1
1

Drug Discovery

(228 Products)

Bringing a new medicine to market is a process that cost about $1bn and can take up to 15 years. With the pharmaceutical industry facing multiple crises, budgets for research being squeezed and tough scientific challenges looming, academics and patients' groups are concerned we will not have the drugs necessary to treat future ills. More challenges will be posed by the imminent expiry of patents for some of the most lucrative drugs. The old model of drug discovery seems to be no longer efficient.

What is the future scenario of R&D? Keep track of the latest developments, trends and issues in this crucial sector of the huge pharmaceuticals industry with the publications listed under Research and Markets’ Drug Discovery category. You will find a wide range of academic and scientific textbooks on the latest R&D techniques, as well as top quality market reports with historical data and forecasts. Show Less
Read more

Inhaled Drug Delivery to 2022

The upper airway diseases Asthma and COPD remain significant health challenges for both patients and clinicians. Inhalers that combine two drugs indicated for treating upper airway diseases in one...

March 2015
FROM

Drug Discovery Technologies - A Global Market Overview

The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the...

August 2014
FROM

Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014

REPORT DESCRIPTION This report is a comprehensive analysis and market study of new developments relating to early-stage minimally-invasive biomarkers in Alzheimer's disease, which have been 'functionally...

August 2014
FROM

Nonalcoholic steatohepatitis (NASH) - Pipeline Analysis

This report gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical...

July 2015
FROM
Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends) Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends) - Product Thumbnail Image

Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends)

Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends) Automation is influencing...

March 2015
FROM

High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018

'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology,...

February 2014
FROM

Circulating Tumour Cells (CTCs) and Circulating Nucleic Acids (CNAs) in Research, Clinical & Diagnostics and in Drug R&D: An Integrated Market Study of Developments, Growth Areas and Opportunities

Market findings from this integrated study are based on 'real world' laboratory data, provided by end-users who investigate Circulating Tumour Cells (CTCs) and Circulating Nucleic Acids (CNAs) in the...

May 2014
FROM

Brazil: Clinical Development Country Profile

This report provides insight into the clinical trial regulation and development environment, sponsor and service provider activities, and population “health status” for Brazil. METHODOLOGIES Authors...

January 2014
FROM

Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition

For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process 'Outsourcing in Drug Discovery' provides...

April 2014
FROM

Risk – Reward of Developing a Herceptin Biosimilar – A Thorough Assessment

Herceptin exclusivity is expiring in major geographies and many Biosimilar players (both experienced and new entrant) are looking to have a share of this potential $6billion pie Herceptin sales are...

September 2012
FROM

Advances in the Orphan Drugs Market 2015

As well as outlining the regulatory environment for orphan drugs in key markets, this report highlights the areas where there is a significant unmet clinical need and provides an overview of the incentives...

May 2015

CNS Drug News Issue

Generic competition for the 20mg version of Teva Pharmaceutical Industries' current multiple sclerosis market leader Copaxone will be available in the US by September. This, coupled with growing sales...

May 2015

R&D Pipeline News - Technology Edition

R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D It is available by monthly or annual subscription The annual subscription consists of 50 issues, the monthly of four or five...

May 2015
FROM

R&D Pipeline News - Therapeutic Area Edition

R&D Pipeline News is your weekly tool for analysis of biopharmaceutical R&D It is available by monthly or annual subscription The annual subscription consists of 50 issues, the monthly of four or five...

May 2015
FROM

R&D Drug Pipeline Database

PRODUCT DESCRIPTION Subscription to La Merie’s proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories Each...

May 2015
FROM

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators

Competitor Analysis: IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators The Competitive Intelligence report about IDO & TDO Inhibitors - Novel Immune Response Checkpoint Modulators...

March 2015
FROM

Frontiers in Computational Chemistry Volume 1

Computational chemistry is a very diverse field spanning from the development and application of linear free energy relationships (QSAR, QSPR), to electronic structure calculations, molecular dynamics...

March 2015

Analysis of America Movil SAB de CV

Analysis of America Movil SAB de CV. A complete and comprehensive analysis of America Movil SAB de CV, includes an overview of the industry the company operates in, a PEST Framework Analysis of the...

February 2015
FROM

Anti-Angiogenesis Drug Discovery and Development Vol. 2

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular...

December 2014

Topics in Anti-Cancer Research Volume 3

The Topics in Anti-Cancer Research e-Book series covers important advances on both experimental (preclinical) and clinical cancer research in drug development. Major developments in the fields of...

November 2014
Loading Indicator

Our Clients

Pfizer, Inc. CSL Limited Novartis AG Qiagen N.V. Quintiles Transnational Roche Diagnostics Ltd.